Document:

EX-10.13

 Exhibit 10.13 
  

 
 November 16, 2012 

Stephen Hoge 
 250 East 63rd Street 
 Apt 21 D 

New York, NY 10065 
  

	 	Re:	 Employment by Moderna Therapeutics, Inc. 

Moderna Therapeutics, Inc. (the “Company”) is pleased to confirm its offer to employ you as the Senior Vice President
Corporate Development reporting to the CEO. It is understood that you will be employed by the Company in such capacity or such other capacity as may be mutually agreed upon by the Company and you from time to time. Your effective date of hire will
be January 1, 2013 (the “Start Date”), and you will perform services for the Company as a regular, full-time employee. 

Your compensation for this position will initially be at the rate of $290,000 per year, payable monthly in accordance with the Company’s
normal pay schedule. 
 You will be eligible to receive an annual performance bonus. The Company will target a cash bonus of 30% of your
annual base salary rate. The actual bonus percentage is discretionary and will be subject to the Company’s assessment of your performance, as well as business conditions at the Company. The bonus also will be subject to your employment for the
full period covered by the bonus, approval by and adjustment at the discretion of the Board of Directors of the Company (the “Board”) and the terms of any applicable bonus plan. The Company expects to review your job performance on
an annual basis and will discuss with you the criteria which the Company will use to assess your performance for bonus purposes. The Company also may make adjustments in the targeted amount of your annual performance bonus 

Subject to the approval of the Board, you will be granted a stock option to purchase 300,000 shares of the Common Stock of the Company, for a
price per share equal to the fair market value established by the Board at the time of grant (the “Option”). The Option will be subject to time-based vesting, as follow: 25% of the shares underlying the Option will vest on the first
anniversary of the Start Date, and the balance of those shares underlying the Option will vest in equal calendar quarterly installments over the next three years, provided in each case that you continue to provide continuous services to the Company
as of such vesting date. For 50,000 shares of the Common Stock of the Company out of the 300,000 stock option grant, there will be two (2) tranches with one (1) personal goal within 12 months of starting: 25,000 options for achieving goal
one (1), and 25,000 for achieving goal two (2). The two goals will be defined with your manager by end of January 2013. 

  
 161 First
Street    Cambridge    MA    02142    |    Tel:    617 714 6500    |    www.modernatx com

 The company will pay directly for the cost of your full relocation cost from New York, NY to
Boston Area including the movers for packing, moving and unpacking your personal belonging. In addition to your compensation, you may take advantage of various benefits offered by the Company, including group medical and dental insurance, short term
disability coverage, group life insurance and a 401(k) plan. These benefits, of course, may be modified, changed or eliminated from time to time at the sole discretion of the Company, and the provision of such benefits to you in no way changes or
impacts your status as an at-will employee. Where a particular benefit is subject to a formal plan (for example, medical insurance or life insurance), eligibility to participate in and receive any particular
benefit is governed solely by the applicable plan document. Should you ever have any questions about Company benefits, you should ask for a copy of the applicable plan document. 

It is understood that you are an “at-will” employee. You are not being offered employment
for a definite period of time, and either you or the Company may terminate the employment relationship at any time and for any reason without prior notice and without additional compensation to you. 

Your normal place of work will be Cambridge, Massachusetts; however, it is understood that the Company may change your normal place of work
according to the Company’s future needs. Enclosed for your review is a “Confidentiality, Intellectual Property, and Non-Competition/Non-Solicitation
Agreement” (the “Agreement”). This offer of employment is conditioned on your willingness to sign and abide by the terms of the Agreement. You will be expected to sign the Agreement before you report for work. 

Protecting the company by maintaining company confidential information is a critical responsibility of each employee. The company policy is
that employees can ONLY share outside the company the information that is publicly available through the company web site. No other information regarding the company plans, its technology, its research programs or any other topic, can be shared
without a proper current CDA in place. 
 In making this offer, the Company understands, and in accepting it you represent that you are not
under any obligation to any former employer or any person or entity which would prevent, limit, or impair in any way the performance by you of your duties as an employee of the Company. 

The Immigration Reform and Control Act requires employers to verify the employment eligibility and identity of new employees. Enclosed is a
copy of the Form I-9 that you will be required to complete. Please bring the appropriate documents listed on that form with you when you report for work. We will not be able to employ you if you fail to comply
with this requirement. 
 Please indicate your acceptance of this offer by signing and dating the enclosed copy of this letter and returning
it in the enclosed envelope by November 21, 2012. 

  
 -2- 

 Stephen, we look forward to your joining the Company and are pleased that you will be working
with us to build a transformative company for patients. 
  

	
	Very truly yours,
	
	MODERNA THERAPEUTICS, INC.
	
	By: Stephane Bancel
	
	Title: President and Founding CEO
	
	/s/ Stephane Bancel

  

	
	Accepted and Agreed:
	
	Stephen Hoge
	
	/s/ Stephen Hoge
	
	11/27/2012
	Date

  
 -3-EX-10.14

 Exhibit 10.14 

 
 

 
 February 20th, 2014 

Mr. Lorence Kim 
 200 Chambers Street, Apt 9 A 

New York, NY 10007 
  

	 	Re:	 Employment by Moderna Therapeutics, Inc. 

Dear Lorence, 
 Moderna Therapeutics, Inc. (the
“Company”) is pleased to confirm its offer to employ you as Chief Financial Officer. Your effective date of hire will be on or before April 21st (the “Start Date”), and you will perform services for the
Company as a regular, full-time employee. 
 Your initial base salary for this position will be at the rate of $350,000 per year,
payable semi-monthly in accordance with the Company’s normal pay schedule. Your salary will be subject to periodic review and adjustments at the Company’s discretion. 

You will be eligible to receive an annual performance bonus. The Company will initially target the bonus at up to 30% of your annual
salary rate (pro-rated based on your Start Date). The actual bonus percentage is discretionary and will be subject to the Company’s assessment of your performance, as well as business conditions at the
Company. The bonus also will be subject to approval by and adjustment at the discretion of the Board of Directors of the Company (the “Board”) and the terms of any applicable bonus plan. You must be employed on the date a bonus is paid to
earn that bonus. The Company expects to review your job performance on an annual basis and expects to discuss with you the criteria which the Company will use to assess your performance for bonus purposes. 

Subject to the commencement of your employment with the Company, the Company will recommend to the Board of Directors of Moderna LLC, the
Company’s parent entity, that you be eligible to participate in Moderna LLC’s equity incentive program and be granted a ‘‘profits interest” in Moderna LLC, at such time as the Board determines, in an aggregate amount of
240,000 Non-Voting Incentive Units, pursuant to a plan to be adopted by the Board. The Non-Voting Incentive Units shall vest according to the following schedule:
25% of the Non-Voting Incentive Units will vest on the first anniversary of the Start Date, and the remaining 75% of the Non-Voting Incentive Units will vest in equal
calendar quarterly installments over the next three years, provided in each case that you continue to provide continuous services to the Company as of such vesting date. The grant of the Non-Voting Incentive
Units will be conditioned upon your execution of Moderna LLC’s form incentive unit grant agreement and a counterpart signature page to Moderna LLC’s Amended and Restated Limited Liability Agreement (the “Operating Agreement”).
The terms and conditions with respect to your Non-Voting Incentive Units shall be set forth in the equity incentive plan to be adopted by the Board and the associated incentive unit grant agreement and the
Operating Agreement. 

  
 Page 1 of 3 

 The Company will pay reasonable costs associated with your relocation to the Cambridge area.
The Company will determine in its reasonable judgment what, if any, of your relocation expenses are for nondeductible expenses in accordance with applicable law and will comply with associated withholding and tax reporting obligations. In the event
that, at any time within 12 months from your Start Date, you voluntarily terminate your employment with the Company, or the Company terminates you for cause, as reasonably determined by the Company, you agree to reimburse the Company for any
relocation expenses made to you under this provision. 
 The company will pay directly your transportation from NYC and accommodation cost
in Cambridge, until your family relocates to Boston. These cost will be paid until June 2015 at the latest. Moderna will gross-up this taxable income. 

In addition to your compensation, you may take advantage of various benefits offered by the Company. Currently the Company provides group
medical, dental and vision insurance, short term disability coverage, group life insurance and a 401(k) plan. These benefits, of course, may be modified, changed or eliminated from time to time at the sole discretion of the Company, and the
provision of such benefits to you in no way changes or impacts your status as an at-will employee. Where a particular benefit is subject to a formal plan (for example, medical insurance or life insurance),
eligibility to participate in and receive any particular benefit is governed solely by the applicable plan document. Should you ever have any questions about Company benefits, you should ask for a copy of the applicable plan document. You will also
be eligible for vacation pursuant to the Company’s policies. 
 All forms of compensation referred to in this offer letter are subject
to reduction to reflect applicable withholding and payroll taxes and other deductions required by law. 
 It is understood that you are an “at-will” employee. You are not being offered employment for a definite period of time, and either you or the Company may terminate the employment relationship at any time and for any reason without prior
notice and without additional compensation to you. 
 Your normal place of work will be Cambridge, Massachusetts; however, it is understood
that the Company may change your normal place of work according to the Company’s future needs. As a condition of your employment, you will need to enter into a ‘‘Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement”, a copy of which is enclosed. This offer is conditioned on your representation that you are not subject to any confidentiality, non-competition agreement or any other similar type of restriction that may affect your ability to devote full time and attention to your work at the Company. If you have entered into any agreement that may restrict
your activities on behalf of the Company, please provide me with a copy of the agreement as soon as possible. You further represent that you have not used and will not use or disclose any trade secret or other proprietary right of any previous
employer or any other party in the course of your employment with the Company. 
 The Immigration Reform and Control Act requires employers
to verify the employment eligibility and identity of new employees. Enclosed is a copy of the Form I-9 that you will be required to complete. Please bring the appropriate documents listed on that form with you
when you report for work. We will not be able to employ you if you fail to comply with this requirement. 

  
 -2- 

 Please indicate your acceptance of this offer by signing and dating this letter (PDF by
email) and returning it by Monday February 24th. 
 Lorence, we look forward to your joining the Company and are pleased that you will be
working with us to build a transformative company for patients. 
  

			
	Very truly yours,
	
	MODERNA THERAPEUTICS, INC.
		
	By:	 	Stephane Bancel
	
	Title: President and CEO
	
	 /s/ Stephane Bancel

	February 20th, 2014

  

	
	Accepted and Agreed:
	
	Lorence Kim
	
	/s/ Lorence Kim
	Date 2/24/14

  
 -3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]